News and Trends 28 Nov 2022
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus docetaxel or, in collaboration with Bristol Myers Squibb, nivolumab in patients with advanced/metastatic non-small cell…